Ulrich Krasilnikoff

Ulrich Krasilnikoff is an experienced executive currently serving as CEO and CFO of Curasight, a biotech company specialized in cancer diagnosis and treatment through its innovative imaging ligand, uTRACE®. In addition to this role, Krasilnikoff holds various positions including lay judge at Danmarks Domstole, co-owner and board member at Primodan A/S, and chairman of the board at Krasilnikoff A/S, which achieved notable growth as a Gazelle company. Previous roles include CFO and Executive Vice President at BIOFAC Group, board member positions at CARL HANSEN & SØN and AH METAL SOLUTIONS A/S, and associate partner roles at Capidea and Business Broker A/S. Education includes a Master of Business Administration from the University of Southern Denmark and degrees in engineering and business from DTU and Copenhagen Business School, respectively.